US Pharmacopeia Revises Chapter on Handling Hazardous Drugs

Share this content:
General Chapter <800> standards apply to all healthcare personnel who prepare, administer, or otherwise come in contact with hazardous agents.
General Chapter <800> standards apply to all healthcare personnel who prepare, administer, or otherwise come in contact with hazardous agents.

What is the USP <800> and what do I need to know about it as an oncology nurse?
—Name withheld upon request

USP <800> is the current chapter regarding standards for hazardous drugs issued by the US Pharmacopeial Convention. This is a nonprofit organization whose mission is to improve global health through public standards and programs that assist in ensuring the quality, safety, and benefit of medicines and foods. These standards were developed to increase awareness, standardize practice, and reduce the risk of exposure to hazardous drugs. Although the National Institute for Occupational Safety and Health (NIOSH) defines criteria and identifies hazardous drugs, USP developed standards for handling hazardous drugs to minimize the risk to public health.

General Chapter <800> includes the requirements of personnel handling hazardous drugs; facility and engineering controls; procedures for deactivating, decontaminating, and cleaning; spill control; documentation; and medical surveillance. These standards apply to all healthcare personnel who receive, prepare, administer, transport, or otherwise come in contact with hazardous drugs. USP <800> will be enforced by each state's board of pharmacy or their delegated agency effective December 1, 2019.  — Leah Scaramuzzo, MSN, RN-BC, AOCN

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs